Optimizing Clinical Outcomes in Rheumatoid Arthritis: An Expert Interview With Dr. Allan Gibofsky
SmartMobile(TM)Premiere Date: Monday, January 30, 2012
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, January 30, 2013
Note: Credit Is No Longer Available
|Allan Gibofsky, MD, JD, MACR, FACP, FCLM
Professor of Medicine
Weill Cornell Medicine
Co-Director, Clinic for Inflammatory Arthritis
Hospital for Special Surgery
New York, NY
The gap between optimal care and usual care is sizable for many common but devastating diseases like rheumatoid arthritis (RA). Most studies show inadequate adherence in RA in many patients, which can lead to deleterious health effects.(1)
Several effective interventions are available for RA, which offer promise for improvement; however, the interventions are often not used.(2) Many physicians are not aware of currently available tools or proactive interventions to address medication adherence. These physicians would benefit from education related to common causes of suboptimal treatment adherence among patients with RA; measures to monitor and improve adherence; and selection of targeted, pharmacological and nonpharmacological therapies within individualized management plans.
This CME Outfitters Expert Interview™ will address learner-generated questions from a moderated, CME Outfitters Live and On Demand activity pertaining to improving adherence and optimizing outcomes for patients with RA in a text-based, online-interview format. The activity will facilitate closure of the adherence gap that is linked to poorer patient outcomes, including higher disease activity or lack of remission.
- de Achaval S, Suarez-Almazor ME. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Rheumatol. 2010;5(3):313-326. PMID: 20676388.
- Wahl C, Gregoire JP, Teo K, et al. Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes. Healthc Q. 2005;8(1):65-70. PMID: 15715337.
To educate clinicians on the most common causes of suboptimal treatment adherence; improve physician-patient communication about treatment; raise expertise in designing and implementing patient-concordant, multimodal treatment plans that support long-term adherence; and teach strategies for integrating evidence-based, objective measures into clinical practice. Achieving these goals will improve adherence and ultimately outcomes for patients with rheumatoid arthritis.
At the end of this CE activity, participants should be able to:
- Articulate the most common causes of low treatment adherence among patients with RA, and review strategies for effective and proactive communication with patients about the long-term risks of treatment nonadherence.
- Apply evidence-based models, strategies, and objective measures to monitor and improve adherence to a therapeutic regimen in patients with RA.
- Discuss targeted, pharmacological and nonpharmacological therapies for RA within individualized management plans that are in concordance with patients' needs.
Supported by an educational grant from Abbott Laboratories, Centocor Ortho Biotech Services, LLC, and Pfizer Inc.
Physicians, physician assistants, pharmacists, and other health care professionals with an interest in rheumatoid arthritis.
CME Credit (Physicians):
USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-12-004-H01-P (recorded programs)
Activity Type: knowledge-based
Disclosure of Relevant Financial Relationships with Commercial Interests
USF Health and CME Outfitters, LLC, adhere to the ACCME Standards, as well as those of the ACPE, APA, and ANCC, regarding commercial support of continuing medical education. It is the policy of USF Health and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
USF Health and CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Gibofsky has disclosed that he serves on the speakers bureaus of Abbott Laboratories; Amgen Inc.; Pfizer Inc.; Hoffmann-La Roche Inc.; and UCB, Inc. He serves as a consultant to Abbott Laboratories; Amgen Inc.; Pfizer Inc.; Hoffmann-La Roche Inc.; and UCB, Inc. He is a stock shareholder of Abbott Laboratories; Amgen Inc.; Bristol-Myers Squibb; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; and Pfizer Inc.
Disclosures were obtained from the planning committee members and are on file in the USF Health Office of Continuing Professional Development (OCPD) for review. Disclosures were obtained from the USF Health OCPD staff: Nothing to Disclose.
Tony Graham, MD (content/peer reviewer) has no disclosures to report.
Christina Ansted, MPH, CCMEP (planning committee) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
USF Health, CME Outfitters, LLC, the faculty, Abbott Laboratories, Centocor Ortho Biotech Services, LLC, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Equal Opportunity Statement: Events, activities, programs and facilities of the University of South Florida are available to all without regard to race, color, marital status, gender, sexual orientation, religion, national origin, disability, age, Vietnam or disabled veteran status as provided by law and in accordance with the university's respect for personal dignity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).